Pharmacology

Special Issues

Following special issues within this section are currently open for submissions:

• Targeting the β-Catenin/Wnt Signaling for Cancer Therapy (Deadline: 25 June 2023)
• Epigenetics as a Therapeutic Target in Human Diseases (Deadline: 27 June 2023)
• Drug Discovery Targeting the Hippo Signaling Pathway (Deadline: 28 June 2023)
• Therapeutic Targets for Diabetes and Associated Complications (Deadline: 30 June 2023)
• Pharmacotherapy of Thromboembolism (Deadline: 30 June 2023)
• Drug-Induced Cardiotoxicity 2023 (Deadline: 30 June 2023)
• Drug Candidates Target HTLV-1 and HTLV-1-Related Diseases (Deadline: 30 June 2023)
• Pharmacological Modulation of Lipoproteins (Deadline: 30 June 2023)
• Personalized Medicine in Gynecological Cancer (Deadline: 30 June 2023)
• Immune Checkpoint Inhibitor in Cancer Therapy: Recent Advances (Deadline: 30 June 2023)
• Histamine Receptors as Drug Targets (Deadline: 30 June 2023)
• Drug Candidates for the Treatment of Gynecologic Cancer (Deadline: 30 June 2023)
• Monoamine Oxidase as Potential Drug Target (Deadline: 30 June 2023)
• Advances in Non-small Cell Lung Cancer Treatment - Current and Future (Deadline: 30 June 2023)
• Therapeutic Strategies and Targets to Improve the Efficacy of PD-1/PD-L1 Blockade (Deadline: 30 June 2023)
• Multi-Drug Resistance (Deadline: 1 July 2023)
• Drug Discovery Targeting the MAPK-ERK Pathway (Deadline: 5 July 2023)
• Therapeutic Target Developments in Pancreatic Cancer (Deadline: 13 July 2023)
• Adenosine Metabolism-Key Targets in Cardiovascular Pharmacology (Deadline: 14 July 2023)
• Cancer Chemoradiotherapy (Deadline: 15 July 2023)
• Pharmacology of Glaucoma (Deadline: 15 July 2023)
• Ketamine and Ketamine Metabolite Pharmacology (Deadline: 15 July 2023)
• Drug Targets for Head and Neck Cancer (Deadline: 31 July 2023)
• Inflammatory Cytokines as New Therapeutic Targets (Deadline: 31 July 2023)
• Therapeutic Potential of Cannabinoid Receptors Type 1 and 2—Novel Insights for Enhancing the Chance of Clinical Success (Deadline: 31 July 2023)
• New Perspectives in Ocular Pharmacology (Deadline: 31 July 2023)
• Therapeutic Potential for Cannabinoids and Their Receptors (Deadline: 31 July 2023)
• Pharmacological Targets of Bone Homeostasis: Osteoclasts and Osteoblasts (Deadline: 31 July 2023)
• Pharmaceutical Science in Electrochemotherapy (Deadline: 31 July 2023)
• Development of Mitochondrial Pharmacology for Common Pathologies 2023 (Deadline: 31 July 2023)
• Recent Advances in the Pharmacology of Serotonin and Its Receptors (Deadline: 31 July 2023)
• Pharmacotherapy of Neuropathic Pain (Deadline: 31 July 2023)
• Pharmacokinetics (PK)/Pharmacodynamics (PD) Study in Drug Discovery and Development (Deadline: 31 July 2023)
• Adipose Tissue as a Therapy and Therapeutic Target for Human Diseases (Deadline: 31 July 2023)
• Potassium Channels as Novel Therapeutic Targets (Deadline: 31 July 2023)
• Pharmacology of Pediatric Medicines (Deadline: 6 August 2023)
• Drug Candidates for the Treatment of Obesity (Deadline: 15 August 2023)
• Migraine: Experimental Models and Novel Therapeutic Target (Deadline: 15 August 2023)
• Recent Developments of Coagulation Factor Products in Hemophilia Treatment (Deadline: 20 August 2023)
• Drug Therapy for Glioma (Deadline: 23 August 2023)
• Drug Treatments for Inflammatory Bowel Diseases (Deadline: 29 August 2023)
• Pharmacokinetics and Pharmacodynamics of Psychoactive Substances: Clinical and Forensic Aspects 2023 (Deadline: 30 August 2023)
• Therapeutics Agents for Neural Repair 2023 (Deadline: 31 August 2023)
• Novel Target for the Treatment of Itch (Pruritus) and Pruritus-Related Pain of Different Origin (Deadline: 31 August 2023)
• Toxicological Effects of Drug Abuse and Its Consequences on Health (Deadline: 31 August 2023)
• Pharmacological Activities of Schiff Bases and/or Their Metal Complexes (Deadline: 31 August 2023)
• Adjuvant Therapies for Cancer Treatment (Deadline: 31 August 2023)
• Dopamine Receptors and Their Heteroreceptor Complexes Give Novel Targets for Drug Development (Deadline: 31 August 2023)
• Metformin: Mechanism and Application 2023 (Deadline: 31 August 2023)
• Multidrug Resistance in ESKAPE Bacteria and Pathogens (Deadline: 31 August 2023)
• Recent Advances in TGF-β Inhibitors for the Therapeutic Management of Cancer and Fibrosis (Deadline: 31 August 2023)
• Pharmacotherapy of Kidney Diseases (Deadline: 31 August 2023)
• Pharmacotherapy of Bone Diseases (Deadline: 31 August 2023)
• Peroxisome Proliferator-Activated Receptor (PPAR): The Novel Pharmaceutical Target (Deadline: 31 August 2023)
• Calcium-Permeable Ion Channels as Targets in Pharmacotherapy (Deadline: 31 August 2023)
• The Pharmacological Management of Skeletal Muscle to Bone Cross Talk (Deadline: 15 September 2023)
• Targeting Thyroid Cancer: From Biology to Therapeutic Strategies (Deadline: 15 September 2023)
• Purinergic Signaling: A New Pharmacological Target (Deadline: 15 September 2023)
• NMDA Receptor-Based Therapeutics (Deadline: 15 September 2023)
• Affecting Monoaminergic Transmission as the Method to Treat the Cognitive Impairments of Different Origins (Deadline: 20 September 2023)
• Pharmacological Treatments for Melanoma (Deadline: 20 September 2023)
• Cardiovascular Neuromodulatory Therapy (Deadline: 30 September 2023)
• Drug Candidates for the Treatment of Endocrinopathies (Deadline: 30 September 2023)
• Cardiac Electrophysiology and Pharmacology (Deadline: 30 September 2023)
• Gut Microbiota Metabolites in Intestinal Inflammation and Fibrosis (Deadline: 30 September 2023)
• Current Therapies for Endometriosis, Adenomyosis and Endometrial Cancer (Deadline: 30 September 2023)
• Pharmacogenomics - A Genetic Approach to Drug Therapy and Development (Deadline: 30 September 2023)
• Drug-Induced and Herbal Hepatotoxicity and Methods of Its Prevention (Deadline: 30 September 2023)
• Mechanisms and Applications of Metformin in Human Diseases (Deadline: 30 September 2023)
• Novel Therapeutic Targets in Cancer 2023 (Deadline: 30 September 2023)
• Microglia and Astrocytes as Drug Targets (Deadline: 30 September 2023)
• Advances in Neuropharmacology of Drug Abuse (Deadline: 30 September 2023)
• Cancer Drugs Treatment and Toxicity 2023 (Deadline: 30 September 2023)
• Multi-target Drug Treatments for Neurodegenerative Disease (Deadline: 30 September 2023)
• Drug-Drug Interactions (DDI) and Personalized Medicine in Oncology (Deadline: 30 September 2023)
• Drug Candidates for the Treatment of Atopic Dermatitis (Deadline: 1 October 2023)
• Drug Candidates for the Treatment of Metabolic Syndrome (Deadline: 15 October 2023)
• Therapeutic Agents for Neurological Disorders 2023 (Deadline: 20 October 2023)
• Kynurenine Pathway: A Novel Therapeutic Opportunity (Deadline: 27 October 2023)
• Pharmacological Treatment of Colorectal Cancer (Deadline: 30 October 2023)
• Advances in Behavioral Psychopharmacology (Deadline: 31 October 2023)
• Therapeutics for Ferroptosis in CNS Disease (Deadline: 31 October 2023)
• Insights into Vitamin E Therapy (Deadline: 31 October 2023)
• Recent Advances in Psychopharmacology (Deadline: 31 October 2023)
• Targeted Drug Therapy for Lymphoma 2023 (Deadline: 31 October 2023)
• Oncolytic Viruses: New Cancer Immunotherapy Drugs (Deadline: 31 October 2023)
• Drug-Induced Neurotoxicity (Deadline: 31 October 2023)
• New Insights Into Therapy for Alzheimer’s and Other Neurodegenerative Diseases (Deadline: 31 October 2023)
• Pharmacology and Therapeutics of Asthma (Deadline: 31 October 2023)
• Pharmacological Treatment of Hearing Loss (Deadline: 31 October 2023)
• Targeting Apoptosis as a Strategy for Developing New Drugs (Deadline: 15 November 2023)
• Therapy for Atopic Dermatitis, Contact Dermatitis and Chronic Urticaria: Recent Advances (Deadline: 17 November 2023)
• Purinergic Receptors and Ectonucleotidases as Novel Therapeutic Targets (Deadline: 22 November 2023)
• Novel Therapies for the Treatment of Skin Diseases (Deadline: 30 November 2023)
• Combining Immunotherapy and Targeted Therapies in Cancer Treatment (Deadline: 30 November 2023)
• Potential Therapeutic Targets for the Treatment of Pathological Pain (Deadline: 30 November 2023)
• Novel Therapeutic Target for Hepatocellular Carcinoma (Deadline: 30 November 2023)
• Pharmacotherapy of Muscle Dystrophies (Deadline: 30 November 2023)
• Current Frames on Cardiotoxicology of New and Old Anticancer Drugs (Deadline: 30 November 2023)
• Chemokines and Chemokine Receptors (Deadline: 30 November 2023)
• Antidepressant Drug (Deadline: 20 December 2023)
• Targeted Therapies for Epilepsy (Deadline: 22 December 2023)
• EPH and Ephrins in Pathogenesis and as Drug Target (Deadline: 23 December 2023)
• Transient Receptor Potential (TRP) Channels as Novel Therapeutic Targets (Deadline: 23 December 2023)
• Effects of Drugs on Ion Channels (Deadline: 30 December 2023)
• Population Pharmacokinetic and Pharmacodynamics (Deadline: 31 December 2023)
• Novel Therapeutic Approaches for Cystic Fibrosis (Deadline: 31 December 2023)
• Rheumatic Diseases: Pathophysiology, Targeted Therapy, Focus on Vascular and Pulmonary Manifestations 2023 (Deadline: 31 December 2023)
• Recent Advances in Drug Discovery and Evaluation for the Treatment of Affective Disorders and Schizophrenia (Deadline: 31 December 2023)
• Pharmacotherapy for Macular Diseases 2023 (Deadline: 31 December 2023)
• Therapeutic Potential for Cannabinoid and Its Receptor (Deadline: 31 December 2023)
• Recent Advances in the Pharmacology of Peripheral Neuropathy (Deadline: 31 December 2023)
• Drug Analysis and Therapeutic Drug Monitoring (Deadline: 30 January 2024)
• Pharmacological Treatment for Gout (Deadline: 31 January 2024)
• Sigma Receptors: Past, Present and Perspectives on Multiple Therapeutic Exploitations (Deadline: 31 March 2024)
• The 20th Anniversary of Pharmaceuticals—Advances in Pharmacology (Deadline: 31 March 2024)
• Psychopharmacology: Recent Advances (Deadline: 30 April 2024)

Topical Collection

Following topical collection within this section is currently open for submissions:

• Old Pharmaceuticals with New Applications